In contrast, the depletion of ILC2s via the transplantation of bone marrow from RORα-deficient mice into IL33tg mice (a type of transgenic mouse overexpressing IL-33) reduced IL-33-induced AD-like inflammation (127). This evidence concerns the gene IL33 and Alzheimer disease.